Skip to main content

Table 2 Frequency of each SNP within the Sample Populations

From: Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's disease

SNP

Alleles

PD-Cohort 1

PD-Cohort 2

PD-ALL

PD-EARLY-ALL

PD-LATE-ALL

All Controls

Control EARLY

Control LATE

rs12374310

GC

71 (41.5%)

78 (42.4%)

149 (42.0%)

72 (45.9%)

62 (41.3%)

81 (50.6%)

35 (49.3%)

46 (51.7%)

 

CC

70 (40.9%)

77 (41.8%)

147 (41.4%)

55 (35.0%)

68 (45.4%)

49 (30.6%)

21 (29.6%)

28 (31.5%)

 

GG

30 (17.6%)

29 (15.8%)

59 (16.6%)

30 (19.1%)

20 (13.3%)

30 (18.8%)

15 (21.1%)

15 (16.8%)

rs2946385

GT

79 (47.0%)

81 (45.5%)

160 (46.2%)

72 (47.4%)

65 (44.5%)

80 (50.3%)

38 (53.5%)

42 (47.7%)

 

GG

60 (35.7%)

70 (39.3%)

130 (37.6%)

59 (38.8%)

54 (37.0%)

52 (32.7%)

21 (29.6%)

31 (35.2%)

 

TT

29 (17.3%)

27 (15.2%)

56 (16.2%)

21 (13.8%)

27 (18.5%)

27 (17.0%)

12 (16.9%)

15 (17.1%)

rs2946386

GC

52 (30.8%)

77 (42.1%)

129 (36.5%)

55 (35.7%)

61 (40.7%)

49 (30.4%)

17 (23.6%)

32 (36.0%)

 

CC

104 (61.5%)

93 (50.8%)

197 (55.9%)

88 (57.2%)

77 (51.3%)

98 (60.9%)

48 (66.7%)

50 (56.1%)

 

GG

13 (7.7%)

13 (7.1%)

27 (7.6%)

11 (7.1%)

12 (8.0%)

14 (8.7%)

7 (9.7%)

7 (7.9%)

rs2970848

AG

76 (45.0%)

81 (44.3%)

157 (44.6%)

74 (47.7%)

60 (40.5%)

80 (50.0%)

32 (44.4%)

48 (54.5%)

 

AA

80 (47.3%)

81 (44.3%)

161 (45.7%)

70 (45.2%)

69 (46.6%)

74 (46.3%)

37 (51.4%)

37 (42.0%)

 

GG

13 (7.7%)

21 (11.4%)

34 (9.7%)

11 (7.1%)

19 (12.9%)

6 (3.7%)

3 (4.2%)

3 (3.5%)

rs2970855

AT

80 (47.0%)

93 (50.5%)

173 (48.9%)

78 (49.7%)

72 (48.3%)

78 (49.1%)

32 (45.1%)

46 (52.3%)

 

TT

69 (40.6%)

63 (34.3%)

132 (37.3%)

60 (38.2%)

53 (35.6%)

59 (37.1%)

31 (43.7%)

28 (31.8%)

 

AA

21 (12.4%)

28 (15.2%)

49 (13.8%)

19 (12.1%)

24 (16.1%)

22 (13.8%)

8 (11.3%)

14 (15.9%)

rs2970865

TC

56 (33.2%)

77 (41.6%)

133 (37.6%)

57 (36.5%)

62 (41.3%)

52 (32.3%)

18 (25.0%)

34 (38.2%)

 

TT

105 (62.1%)

96 (51.9%)

201 (56.8%)

30 (57.7%)

79 (52.7%)

98 (60.9%)

48 (66.7%)

50 (56.2%)

 

CC

8 (4.7%)

12 (6.5%)

20 (5.6%)

9 (5.8%)

9 (6.0%)

11 (6.8%)

6 (8.3%)

5 (5.6%)

rs2970866

AG

55 (32.2%)

75 (41.4%)

130 (37.0%)

54 (34.8%)

62 (41.9%)

50 (31.5%)

17 (23.6%)

33 (37.9%)

 

AA

105 (61.4%)

94 (52.0%)

199 (56.5%)

90 (58.1%)

77 (52.0%)

97 (61.0%)

48 (66.7%)

49 (56.3%)

 

GG

11 (6.4%)

12 (6.6%)

23 (6.5%)

11 (7.1%)

9 (6.1%)

12 (7.5%)

7 (9.7%)

5 (5.8%)

rs2970869

GA

55 (33.1%)

78 (42.2%)

133 (37.9%)

57 (37.0%)

62 (41.6%)

52 (32.1%)

18 (24.7%)

34 (38.2%)

 

GG

104 (62.7%)

95 (51.3%)

199 (56.7%)

89 (57.8%)

78 (52.4%)

98 (60.5%)

48 (65.8%)

50 (56.2%)

 

AA

7 (4.2%)

12 (6.5%)

19 (5.4%)

8 (5.2%)

9 (6.0%)

12 (7.4%)

7 (9.5%)

5 (5.6%)

rs2970870

TC

83 (49.4%)

87 (49.1%)

170 (49.3%)

77 (51.0%)

73 (50.0%)

72 (45.6%)

26 (36.6%)

46 (52.9%)

 

TT

54 (32.1%)

58 (32.8%)

112 (32.4%)

47 (31.1%)

47 (31.1%)

57 (36.1%)

29 (40.9%)

28 (32.2%)

 

CC

31 (18.5%)

32 (18.1%)

63 (18.3%)

27 (17.9%)

27 (17.9%)

29 (18.3%)

16 (22.5%)

13 (14.9%)

rs2970873

CT

40 (23.4%)

60 (33.0%)

100 (28.3%)

40 (25.3%)

48 (32.6%)

41 (25.8%)

15 (21.1%)

26 (29.6%)

 

CC

126 (73.7%)

116 (63.7%)

242 (68.6%)

114 (72.2%)

93 (63.3%)

114 (71.7%)

53 (74.7%)

61 (69.3%)

 

TT

5 (2.9%)

6 (3.3%)

11 (3.1%)

4 (2.5%)

6 (4.1%)

4 (2.5%)

3 (4.2%)

1 (1.1%)

rs4383605

TG

59 (35.1%)

73 (40.1%)

132 (37.7%)

55 (35.7%)

60 (40.5%)

59 (37.1%)

25 (35.2%)

34 (38.6%)

 

TT

89 (53.0%)

97 (53.3%)

186 (53.1%)

84 (54.6%)

77 (52.0%)

83 (52.2%)

37 (52.1%)

46 (52.3%)

 

GG

20 (11.9%)

12 (6.6%)

32 (9.2%)

15 (9.7%)

11 (7.4%)

17 (10.7%)

9 (12.7%)

8 (9.1%)

rs6821591

CT

92 (53.8%)

83 (46.3%)

175 (50.0%)

72 (46.8%)

74 (50.3%)

80 (50.3%)

40 (56.3%)

40 (45.4%)

 

CC

39 (22.8%)

54 (30.2%)

93 (26.8%)

37 (24.0%)

47 (32.0%)

31 (19.5%)

7 (9.9%)

24 (27.3%)

 

TT

39 (22.8%)

42 (23.5%)

81 (23.2%)

45 (29.2%)

26 (17.7%)

48 (30.2%)

24 (33.8%)

24 (27.3%)

rs7665116

CT

39 (22.8%)

43 (23.2%)

82 (23.0%)

41 (25.9%)

31 (20.7%)

56 (35.0%)

26 (36.1%)

30 (34.1%)

 

TT

128 (74.9%)

140 (75.7%)

268 (75.3%)

114 (72.2%)

119 (79.3%)

102 (63.8%)

45 (62.5%)

57 (64.8%)

 

CC

4 (2.3%)

2 (1.1%)

6 (1.7%)

3 (1.9%)

0 (0.0%)

2 (1.2%)

1 (1.4%)

1 (1.1%)

rs7695542

CT

17 (10.1%)

9 (4.9%)

26 (7.4%)

41 (26.0%)

31 (20.7%)

15 (9.3%)

8 (11.1%)

7 (7.9%)

 

TT

151 (89.9%)

176 (95.1%)

327 (92.6%)

114 (72.1%)

119 (79.3%)

145 (90.1%)

64 (88.9%)

81 (91.0%)

 

CC

0 (0.0%)

0 (0.0%)

0 (0.0%)

3 (1.9%)

0 (0.0%)

1 (0.6%)

0 (0.0%)

1 (1.1%)

rs8192678

GA

95 (53.0%)

88 (44.3%)

183 (48.4%)

89 (52.7%)

69 (43.7%)

83 (48.0%)

47 (58.0%)

36 (39.1%)

 

GG

70 (39.2%)

93 (46.7%)

163 (43.1%)

66 (39.0%)

75 (47.5%)

73 (42.2%)

26 (32.1%)

47 (51.1%)

 

AA

14 (7.8%)

18 (9.0%)

32 (8.5%)

14 (8.3%)

14 (8.9%)

17 (9.8%)

8 (9.9%)

9 (9.8%)

ND3 A10398G

A

143 (79.9%)

149 (75.6%)

292 (77.7%)

132 (79.0%)

119 (75.3%)

129 (74.6%)

60 (74.1%)

69 (75.0%)

 

G

36 (20.1%)

48 (24.3%)

84 (22.3%)

35 (21.0%)

39 (24.7%)

44 (25.4%)

21 (25.9%)

23 (25.0%)

  1. Data are presented for both cohorts and for each subgroup that was analyzed. The PD-ALL, PD- ALL-EARLY and PD-ALL-LATE groups represent sub-groups drawn from both PD cohorts within restricted age parameters. Percentages are calculated from column data.